Marcel Schmocker
Directeur/Membre du Conseil chez BioXpress Therapeutics SA
Profil
Marcel Schmocker is currently a Director at BioXpress Therapeutics SA and IPRIS AG.
He was formerly a Director at Selexis SA. He received his graduate degree from Duke University in 1986 and his undergraduate degree from the University of Bern in 1983.
Postes actifs de Marcel Schmocker
Sociétés | Poste | Début |
---|---|---|
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Directeur/Membre du Conseil | - |
IPRIS AG
IPRIS AG Miscellaneous Commercial ServicesCommercial Services IPRIS AG provides intellectual property management solutions. The firm’s offering renewals, European validation, nationalization and renewal portal. The company was founded by Bruno H. Dalle Carbonare and Hugo van Buel in 2004 and is headquartered in Basel, Switzerland. | Directeur/Membre du Conseil | - |
Anciens postes connus de Marcel Schmocker
Sociétés | Poste | Fin |
---|---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Directeur/Membre du Conseil | - |
Formation de Marcel Schmocker
University of Bern | Undergraduate Degree |
Duke University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
BioXpress Therapeutics SA
BioXpress Therapeutics SA BiotechnologyHealth Technology BioXpress Therapeutics SA provides biosimilar biologic APIs for unmet need indications such as cancer, inflammation and autoimmunity. The company is headquartered in Plan-les-Ouates, Switzerland. | Health Technology |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |
IPRIS AG
IPRIS AG Miscellaneous Commercial ServicesCommercial Services IPRIS AG provides intellectual property management solutions. The firm’s offering renewals, European validation, nationalization and renewal portal. The company was founded by Bruno H. Dalle Carbonare and Hugo van Buel in 2004 and is headquartered in Basel, Switzerland. | Commercial Services |